Biocorrx Stock Analysis
| BICX Stock | USD 0.30 0.06 16.67% |
BioCorRx is fairly valued with Real Value of 0.29 and Hype Value of 0.3. The main objective of BioCorRx otc analysis is to determine its intrinsic value, which is an estimate of what BioCorRx is worth, separate from its market price. There are two main types of BioCorRx's stock analysis: fundamental analysis and technical analysis.
The BioCorRx otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
BioCorRx |
BioCorRx OTC Stock Analysis Notes
About 59.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.69. BioCorRx last dividend was issued on the 22nd of January 2019. The entity had 1:100 split on the 22nd of January 2019. BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. Biocorrx operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange.The quote for BioCorRx is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on BioCorRx please contact Brady Granier at 714 462 4880 or go to https://www.biocorrx.com.BioCorRx Investment Alerts
| BioCorRx is way too risky over 90 days horizon | |
| BioCorRx has some characteristics of a very speculative penny stock | |
| BioCorRx appears to be risky and price may revert if volatility continues | |
| BioCorRx has a very high chance of going through financial distress in the upcoming years | |
| BioCorRx currently holds 174.16 K in liabilities with Debt to Equity (D/E) ratio of 5.72, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BioCorRx has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist BioCorRx until it has trouble settling it off, either with new capital or with free cash flow. So, BioCorRx's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioCorRx sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioCorRx to invest in growth at high rates of return. When we think about BioCorRx's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 48.27 K. Net Loss for the year was (5.21 M) with profit before overhead, payroll, taxes, and interest of 42.39 K. | |
| BioCorRx currently holds about 81.76 K in cash with (3.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 59.0% of BioCorRx shares are held by company insiders |
BioCorRx Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioCorRx's market, we take the total number of its shares issued and multiply it by BioCorRx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 28th of November, BioCorRx shows the Mean Deviation of 4.81, downside deviation of 21.25, and Risk Adjusted Performance of 0.0529. BioCorRx technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down nineteen technical drivers for BioCorRx, which can be compared to its peers.BioCorRx Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BioCorRx middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BioCorRx. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
BioCorRx Outstanding Bonds
BioCorRx issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioCorRx uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioCorRx bonds can be classified according to their maturity, which is the date when BioCorRx has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
BioCorRx Predictive Daily Indicators
BioCorRx intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioCorRx otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.83 | |||
| Day Median Price | 0.3 | |||
| Day Typical Price | 0.3 | |||
| Price Action Indicator | (0.03) | |||
| Period Momentum Indicator | (0.06) |
BioCorRx Forecast Models
BioCorRx's time-series forecasting models are one of many BioCorRx's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioCorRx's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About BioCorRx OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how BioCorRx prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioCorRx shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as BioCorRx. By using and applying BioCorRx OTC Stock analysis, traders can create a robust methodology for identifying BioCorRx entry and exit points for their positions.
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. Biocorrx operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding BioCorRx to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Additional Tools for BioCorRx OTC Stock Analysis
When running BioCorRx's price analysis, check to measure BioCorRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCorRx is operating at the current time. Most of BioCorRx's value examination focuses on studying past and present price action to predict the probability of BioCorRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCorRx's price. Additionally, you may evaluate how the addition of BioCorRx to your portfolios can decrease your overall portfolio volatility.